Factors affecting the immunogenicity and potency of tetanus toxoid: Implications for the elimination of neonatal and non-neonatal tetanus as public health problems

Bulletin of the World Health Organization

Volumn 75, Issue 1, 1997, Pages 81-93

  Dietz, V ^a,b   Galazka, A ^c   Van Loon, F ^a,b   Cochi, S ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXOID;

DRUG POTENCY; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; MALARIA; NEWBORN INFECTION; PUBLIC HEALTH; RETINOL DEFICIENCY; REVIEW; TETANUS; VACCINATION;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DISEASES; HEALTH; HEALTH SERVICES; IMMUNIZATION; INFECTIONS; LITERATURE REVIEW; NEONATAL DISEASES AND ABNORMALITIES; PRIMARY HEALTH CARE; PUBLIC HEALTH; TETANUS; VACCINATION; VACCINES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG STORAGE; FEMALE; FREEZING; HUMANS; IMMUNITY; INFANT, NEWBORN; MALARIA; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; NUTRITION DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PUBLIC HEALTH; TETANUS; TETANUS TOXOID;

EID: 0030926399     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Rashman M et al. Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh. Bulletin of the World Health Organization, 1982, 60: 261-267.
2. Schofield FD, Tucker VM, Westbrook GR. Neonatal tetanus in New Guinea, effect of active immunization in pregnancy. Lancet, 1961: 785-789.
3. Newell KW et al. The use of toxoid for the prevention of tetanus neonatorum. Bulletin of the World Health Organization, 1966, 35: 863-871.
4. Chen ST et al. Timing of antenatal tetanus immunization for effective protection of the neonate. Bulletin of the World Health Organization, 1983, 61: 159-165.
5. Jones TS. The use of tetanus toxoid for the prevention of neonatal tetanus in developing countries. In: Recent advances in immunization, a bibliographic review. Washington, DC, Pan American Health Organization, 1983 (Scientific Publication No. 451).
6. Progress toward the global elimination of neonatal tetanus, 1989-1993. Morbidity and mortality weekly report, 1994, 43: 885-887; 43: 893-894.
7. Progress toward the global elimination of neonatal tetanus, 1989-1993. Morbidity and mortality weekly report, 1994, 43: 885-887; 43: 893-894.
8. Owa JA, Makinde OO. Neonatal tetanus in babies of women immunized with tetanus toxoid during pregnancy. Tropical doctor, 1990, 20: 156-157.
9. Ghosh JB. Prevention of tetanus neonatorum. Indian pediatrics, 1990, 27: 210.
10. Owa JA, Makinde OO. Neonatal tetanus in babies of immunized mothers. Journal of tropical pediatrics, 1990, 36: 143-144.
11. Dobbelaer R. A comparison between the World Health Organization and European Pharmacopoeia methods for the potency testing of adsorbed tetanus toxoid. In: Manclark CR, ed. Proceedings of an informal consultation on the World Health Organization requirements for diphtheria, tetanus, pertussis and combined vaccines, Geneva 30 May-1 June 1988. Bethesda, MD, USA, U.S. Public Health Service, Food and Drug Administration, 1991.
12. Simonsen O, Bentzon MW, Heron I. Modification of the ELISA for the estimation of tetanus antitoxin in human sera. Journal of biological standardization, 1987, 15: 143-157.
13. Expanded Programme on Immunization. Influence of malaria on the immune response to tetanus toxoid in pregnancy. Weekly epidemiological record, 1982, 59: 45-46.
14. Brabin BJ et al. The influence of malaria and gestation on the immune response to one and two doses of adsorbed tetanus toxoid in pregnancy. Bulletin of the World Health Organization, 1984, 62: 919-930.
15. McGregor I, Barr M. Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1962, 56: 364-367.
16. Greenwood BM et al. Immunosuppression in children with malaria. Lancet, 1972, 22: 169-172.
17. Edsall G et al. Malnutrition and the immune response to tetanus toxoid, In: Proceedings of the Fourth International Conference on Tetanus, 6-12 April 1975, Dakar, Senegal. Lyon, Fondation Mérieux, 1975: 683-685.
18. Corrigall RJ. Asymptomatic malaria parasitaemia and the antibody response to tetanus toxoid vaccination. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1988, 82: 540-541.
19. Monjour L et al. Etude de l'immunité humorale et cellulaire après vaccination antitétanique chez l'enfant african malnutri et paludéen. Bulletin of the World Health Organization, 1982, 60: 589-596.
20. Gilles HM et al. The Malumfashi Project - an epidemiological, clinical and laboratory study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1983, 77: 24-31.
21. Bradley-Moore AM et al. Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. Annals of medical parasitology, 1985, 79: 563-573.
22. Tarzaali A, Viens P, Quevillon M. Inhibition of the immune response to whooping cough and tetanus vaccines by malaria infection, and the effect of pertussis adjuvant. American journal of tropical medicine and hygiene, 1977, 26: 520-524.
23. Katz SP. Effects of malnutrition and parasitic infections on the immune response to vaccines. Evaluation of the risks associated with administering vaccines to malnourished children. In: Recent advances in immunization. Washington, DC, Pan American Health Organization, 1983: 81-89 (Scientific Publication No. 451).
24. Semba RD et al. Depressed immune response to tetanus in children with vitamin A deficiency. Journal of nutrition, 1992, 122: 101-107.
25. Neumann CG et al. Immunologic responses in malnourished children. American journal of clinical nutrition, 1975, 28: 89-104.
26. Chandra RK. Immunocompetence in undernutrition. Journal of pediatrics, 1972, 81: 1194-2000.
27. Geefhuysen J et al. Impaired cellular immunity in kwashiorkor with improvement after therapy. British medical journal, 1971, 2: 527.
28. Reddy V, Bhaskaram C, Raghuramulu N. Immunological responses in malnourished children. Indian pediatrics, 1977, 14: 255-258.
29. Chandra RK. Immunocompetence in undernutrition. Journal of pediatrics, 1972, 81: 1194-2000.
30. Chandra RK. Fetal malnutrition and postnatal immunocompetence. American journal of diseases of children, 1975, 129: 450-454.
31. Ghosh S et al. DPT immunization and malnutrition. Indian pediatrics, 1980, 2: 123-125.
32. Chandra RK, Chandra S, Gupta S. Antibody affinity and complexes after immunization with tetanus toxoid in protein-energy malnutrition. American journal of clinical nutrition, 1984, 40: 131-134.
33. Price P, Bell RG. The effects of nutritional rehabilitation on antibody production in protein-deficient mice. Immunology, 1976, 31: 953.
34. Kutty PM, Mohanram M, Vinodini R. Humoral immune response in vitamin A deficient children. Acta vitaminol Enzymol, 1981, 4: 231-235.
35. Brown KH et al. Failure of a large dose of vitamin A to enhance the antibody response to tetanus toxoid in children. American journal of clinical nutrition, 1989, 33: 212-217.
36. Krishnan S et al. Effect of vitamin A and proteincalorie undernutrition on immune responses. Immunology, 1974, 27: 383-392.
37. Kinoshita M et al. Immunological memory to tetanus toxoid is established and maintained in the vitamin-A-depleted rat. FASEB journal, 1991, 5: 2473-2781.
38. Hardegree MC et al. Immunization against neonatal tetanus in New Guinea. 2. Duration of primary antitoxin responses to adjuvant tetanus toxoids and comparison of booster responses to adjuvant and plain toxoids. Bulletin of the World Health Organization, 1970, 43: 439-451.
39. Katitch RV. Valeur de l'immunité antitétanique, après injection de rappel, chez les vaccinées en cours de gravidité. Revue d'immunologie, et de thérapie antimicrobienne, 1960, 24: 521-524.
40. Brambell FWR. The transmission of passive immunity from mother to young. Amsterdam, NorthHolland, 1970.
41. Kohler FP, Farr RS. Elevation of cord over maternal lgG immunoglobulin: evidence for an active placental lgG transport. Nature, 1966, 210: 1070-1071.
42. Gitlin D et al. The selectivity of the human placenta in the transfer of plasma proteins from mother to fetus. Journal of clinical investigation, 1964, 43: 1938-1951.
43. Pitcher-Willmot RW, Hindocha P, Wood CBS. The placental transfer of lgG subclass in human pregnancy. Clinical and experimental immunology, 1980, 41: 303-359.
44. Michaux JL, Heremans JF, Hitzig WH. Immunoglobulin levels in cord-blood serum of Negroes and Caucasians. Tropical and geographical medicine, 1966, 18: 10-14.
45. Logie DE et al. Plasma immunoglobulin concentrations in mothers and newborn children with special reference to placental malaria. Studies in the Gambia, Nigeria, and Switzerland. Bulletin of the World Health Organization, 1973, 49: 547-554.
46. Rowe DS et al. Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clinical and experimental immunology, 1968, 3: 63-79.
47. Gendrel D et al. Transfert placentarie des anticorps antitétaniques et protection du nouveau-né. Archives françaises de pediatrie, 1990, 47: 725-729.
48. Gendrel D et al. Placental transfer of tetanus antibodies and protection of the newborn. Journal of tropical pediatrics, 1990, 36: 279-282.
49. Hood N et al. Placental transfer of tetanus toxoid antibodies in Nigerian mothers. Annals of tropical paediatrics, 1994, 14: 179-182.
50. Sangpetchsong V et al. Transfer rate of transplacental immunity to tetanus from nonimmunized and immunized mothers. South-east Asian journal of tropical medicine and hygiene, 1984, 15: 275-280.
51. Sundar S et al. Study of anti-tetanus lgG and lgM levels in maternal and cord sera by enzyme-linked immunosorbent assay (ELISA). Indian journal of pediatrics, 1990, 57: 763-770.
52. Maselle SY et al. Maternal and foetal tetanus toxoid antibody levels following immunization in pregnancy. Journal of obstetrics and gynaecology of Eastern and Central Africa, 1989, 8: 11-14.
53. Galbraight RM et al. The human materno-foetal relationship in malaria: histological, ultrastructural and immunopathological studies of the placenta. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1980, 74: 61-72.
54. Brair ME et al. Reduced transfer of tetanus antibodies with placental malaria. Lancet, 1994, 343: 208-209.
55. Orenstein WA, Weisfield JS, Halsey NA. Diphtheria and tetanus toxoids and pertussis vaccine, combined. In: Recent advances in immunization: a bibliographic review. Washington, DC, Pan American Health Organization, 1983 (Scientific Publication No. 451).
56. Zuber PLP et al. Tetanus in Switzerland 1980-1989. European journal of epidemiology, 1993, 9: 617-624.
57. Lonbard L, Lepoutre A. Le tétanos en France en 1991 et 1992. Bulletin épidémiologique hebdomadaire, 1993, 28: 125-126.
58. Blaszczyk J. [Tetanus in 1993]. Przegl epidemiologiczny, in press (in Polish).
59. Prevots R et al. Tetanus surveillance - United States, 1989-1990. Morbidity and mortality weekly report, 1992, 41(suppl. 8): 1-9.
60. Afonja AOG, Jaiyeola BO, Tunwashe OL. Tetanus in Lagos: a review of 228 adult Nigerian patients. Journal of tropical medicine and hygiene, 1973, 76: 171-174.
61. Cosnard G, Joullie M, Davin R. Le tétanos à l'hôpital de Ouahigouya (Haute Volta). Médecine tropicale, 1977, 37: 45-49.
62. Patel J, Mehta BC. Tetanus: study of 8697 cases. Proceedings of the Fourth International Conference on Tetanus, Dakar, Senegal 6-12 April 1975. Lyon, Foundation Mérieux, 1975: 233-241.
63. Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. American journal of epidemiology, 1978, 108: 145-149.
64. Salomonova K, Vizev S. Immunological reactivity of senescent and old people actively immunized with tetanus toxoid. Zeitschrift für Immunitätsforschung, 1973, 146: 81-90.
65. Salomonova K, Vizev S. Secondary response to boostering by purified aluminum-hydroxide-adsorbed tetanus antitoxin in aging and in aged adults. Immunobiology, 1981, 158: 312-319.
66. Finger H et al. [Tetanus immunity in senium]. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Originale Reihe B, 1975, 161: 188-193 (in German).
67. Kishimoto S et al. Age-related decline in the in vitro and in vivo synthesis of anti-tetanus toxoid antibody in humans. Journal of immunology 1980, 125: 2347-2352.
68. Masar I, Kamienicka L, Novakova I. Immune response of elderly to boosters of tetanus. In: Nistico G, et al. Proceedings of the Eighth International Conference on Tetanus, Leningrad, 25-28 August 1987. Rome, Pythagora Press, 1989: 251-253.
69. Rethy LA, Rethy L. The age and sex dependent features of the development of human immune memory; Annales immunologiae Hungaricae, 1986, 26: 551-562.
70. Rotivel Y et al. Simultaneous vaccination of the elderly with fluid polymerized tetanus toxoid and influenza vaccines. In: Nistico G et al., eds. Proceedings of the Eighth International Conference of Tetanus Leningrad, 25-28 August 1987. Rome, Pythagora Press, 1989: 420-427.
71. Kumar V, Sahai G, Kumar A. Studies on the stability of tetanus and pertussis components of DTP vaccine on exposure to different temperatures. Indian journal of pathology and microbiology, 1982, 25: 50-54.
72. Kindt H et al. Stability of DTP vaccine. Journal of biological standardization, 1974, 2: 183-187.
73. Stainer DW, Hart FE. The stability of bacterial vaccines at elevated temperatures. Developments in biological standardization, 1978, 41: 249-253.
74. Menon PS et al. Field trial on frozen and thawed tetanus toxoid. Indian journal of medical research, 1976, 64: 25-32.
75. Expanded Programme on Immunization. The effects of freezing on the appearance, potency and toxicity of absorbed and unabsorbed DTP vaccine. Weekly epidemiological record, 1980, 55(50): 385-392.
76. Expanded Programmed on Immunization. The effects of freezing on the appearance, potency and toxicity of absorbed and unabsorbed DTP vaccine. Weekly epidemiological record, 1980, 55(51): 396-398.